中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [29]
合肥物质科学研究院 [1]
采集方式
OAI收割 [30]
内容类型
期刊论文 [27]
会议论文 [3]
发表日期
2022 [1]
2021 [2]
2020 [3]
2019 [2]
2018 [2]
2017 [2]
更多
学科主题
筛选
浏览/检索结果:
共30条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Trastuzumab in combination with PEGylated interferon-alpha 1b exerts synergistic antitumor activity through enhanced inhibition of HER2 downstream signaling and antibody-dependent cellular cytotoxicity
期刊论文
OAI收割
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 卷号: 12, 期号: 2, 页码: 549-561
作者:
Xu, Piaopiao
;
Chen, Xiangling
;
Xu, Yongping
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:189/0
  |  
提交时间:2022/06/15
Trastuzumab
PEGylated IFN-alpha 1b
ADCC
HER2-positive cancer
synergistic effect
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells
期刊论文
OAI收割
THORACIC CANCER, 2021, 页码: 9
作者:
Zhang, Mi
;
Quan, Haitian
;
Fu, Li
;
Li, Yun
;
Fu, Haoyu
  |  
收藏
  |  
浏览/下载:66/0
  |  
提交时间:2021/05/24
EGFR‐
mutant non‐
small cell lung cancer
famitinib
HS‐
10296
multi‐
targeted tyrosine kinase inhibitor
third‐
generation EGFR inhibitor
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
期刊论文
OAI收割
AUTOPHAGY, 2021, 卷号: 17
作者:
Klionsky, Daniel J.
;
Abdel-Aziz, Amal Kamal
;
Abdelfatah, Sara
;
Abdellatif, Mahmoud
;
Abdoli, Asghar
  |  
收藏
  |  
浏览/下载:319/0
  |  
提交时间:2021/05/31
Autophagosome
cancer
flux
LC3
lysosome
macroautophagy
neurodegeneration
phagophore
stress
vacuole
YES1amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer
期刊论文
OAI收割
BRITISH JOURNAL OF CANCER, 2020, 页码: 12
作者:
Wang, Lei
;
Wang, Quanren
;
Xu, Piaopiao
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/12/24
Pd-Catalyzed Decarboxylative Olefination: Stereoselective Synthesis of Polysubstituted Butadienes and Macrocyclic P-glycoprotein Inhibitors
期刊论文
OAI收割
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2020, 卷号: 142, 期号: 22, 页码: 9982-9992
作者:
Song, Bichao
;
Xie, Peipei
;
Li, Yingzi
;
Hao, Jiping
;
Wang, Lu
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2020/12/24
A modular biomimetic strategy for the synthesis of macrolide P-glycoprotein inhibitors via Rh-catalyzed C-H activation
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2020, 卷号: 11, 期号: 1, 页码: 8
作者:
Chen, Lu
;
Quan, Haitian
;
Xu, Zhongliang
;
Wang, Hao
;
Xia, Yuanzhi
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/12/24
SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met
期刊论文
OAI收割
CANCER SCIENCE, 2019, 页码: 11
作者:
Tong, Mengya
;
Gao, Mingzhao
;
Xu, Yongping
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:64/0
  |  
提交时间:2020/07/01
AZD9291
c-Met ADC
c-Met overexpression
resistance
SHR-A1403
Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants
期刊论文
OAI收割
CANCER SCIENCE, 2019, 页码: 9
作者:
Gao, Mingzhao
;
Zhu, Hongmei
;
Fu, Li
;
Li, Yun
;
Bao, Xubin
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2020/07/01
AG-221
IDH2
leukemia
R140Q
R172K
STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer
期刊论文
OAI收割
CANCER SCIENCE, 2018, 卷号: 109, 期号: 10, 页码: 3305-3315
作者:
Wang, Lei
;
Wang, Quanren
;
Gao, Mingzhao
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:56/0
  |  
提交时间:2019/01/08
drug resistance
leukemia inhibitory factor receptor
secreted factor
STAT3
trastuzumab-emtansine
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor
期刊论文
OAI收割
CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219
作者:
Xie, Chengying
;
Wan, Xiaozhe
;
Quan, Haitian
;
Zheng, Mingyue
;
Fu, Li
  |  
收藏
  |  
浏览/下载:55/0
  |  
提交时间:2019/01/08
angiogenesis
anlotinib
tyrosine kinase inhibitor
VEGF
VEGFR2